Irinotecan hydrochloride trihydrate
Irinotecan hydrochloride trihydrate Basic information
- Product Name:
- Irinotecan hydrochloride trihydrate
- Synonyms:
-
- Irinotecan hydrochloride trihydrate, >=99%
- (1,4’-bipiperidine)-1’-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hyd
- roxy-3,14-dioxo-1h-pyrano(3’,4’:6,7)indolizino(1,2-b)quinolin-9-ylester,mono
- trihydrate,(s)-hydrochlorid
- IRINOTECAN HYDROCHLORIDE TRIHYDRATE
- IRINOTECAN MONOHYDROCHLORIDE TRIHYDRATE
- IRINOTECAN HCL TRIHYDRATE
- Irinotecan HCL 3H2O
- CAS:
- 136572-09-3
- MF:
- C33H45ClN4O9
- MW:
- 677.18
- EINECS:
- 603-967-2
- Product Categories:
-
- Inhibitors
- Anticancer
- API
- Anti-cancer&immunity
- Mol File:
- 136572-09-3.mol
Irinotecan hydrochloride trihydrate Chemical Properties
- Melting point:
- 250-256°C (dec.)
- Boiling point:
- 257°C(lit.)
- storage temp.
- 2-8°C
- solubility
- Soluble in DMSO (up to 50 mg/ml), in Water (up to 4 mg/ml) or in Ethanol (up to 4 mg/ml).
- form
- White solid.
- color
- Yellow
- Water Solubility
- Soluble in DMSO at 100mg/ml. Soluble in water at 25mg/ml with warming
- Merck
- 14,5091
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO, ethanol or distilled water may be stored at -20° for up to 3 months.
- CAS DataBase Reference
- 136572-09-3(CAS DataBase Reference)
Irinotecan hydrochloride trihydrate Usage And Synthesis
Description
Irinotecan (136572-09-3) is a semi-synthetic derivative of camptothecin (Cat.# 10-1041) that is an FDA approved anticancer drug. It is a prodrug that is converted by tissue esterases to 7-ethyl-10-hydroxycamptothecin (SN-38, Cat.# 10-2425), a potent inhibitor of DNA topoisomerase I.1,2 Although irinotecan is also a topoisomerase inhibitor, SN-38 is approximately 1000 times as potent in purified enzyme studies. In vitro cytotoxicity assays show much greater variability in potency between the two (2-2000 fold).3
Chemical Properties
White powder
Uses
Irinotecan Hydrochloride Trihydrate is a DNA topoisomerase inhibitor.
Definition
ChEBI: A hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active.
brand name
Camptosar (Pharmacia &Upjohn) .
Hazard
Moderately toxic by ingestion.
References
1) Kunimoto et al. (1987) Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin against murine tumors; Cancer Res., 47 5944 2) Mathijssen et al., (2002) Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan; Curr. Cancer Drug Targets, 253 5892 3) Pfizer drug insert
Irinotecan hydrochloride trihydrateSupplier
- Tel
- 13812081281 16789019998
- 13812081281@163
- Tel
- 21-57687675
- yanjie@biocompounds.com
- Tel
- 531-82812892
- sunshinepharm0531@163.com
- Tel
- 021-58180488
- sales@Medchemleader.com
- Tel
- 13818767334
- samwjf@163.com
Irinotecan hydrochloride trihydrate(136572-09-3)Related Product Information
- Irinotecan Impurity 18
- (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride
- Irinotecan hydrochloride
- 12-Hydroxy Irinotecan
- GURKHSYORGJETM-MGDILKBHSA-N
- Irinotecan Impurity 19
- Irinotecan Impurity 24
- Cisplatin
- 5-Fluorouracil
- Topotecan hydrochloride
- Crizotinib
- Oxaliplatin
- Olaparib
- Mesna
- Docetaxel
- 1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride
- 1-benzyl-4-(piperidin-1-yl)-1,2,3,6-tetrahydropyridine
- [1,4'-Bipiperidine]-1'-carboxylic acid